InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Mayersohn Joel David. Director active across 1 company, notably CITIUS ONCOLOGY, INC.. Cumulatively, 1 filings have been recorded. History available since 19 September 2025. The latest transaction was filed on 19 September 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration